Achieve Life Sciences, Inc.

NasdaqCM:ACHV Stock Report

Market Cap: US$127.2m

Achieve Life Sciences Balance Sheet Health

Financial Health criteria checks 4/6

Achieve Life Sciences has a total shareholder equity of $31.4M and total debt of $9.8M, which brings its debt-to-equity ratio to 31.3%. Its total assets and total liabilities are $47.9M and $16.5M respectively.

Key information

31.3%

Debt to equity ratio

US$9.82m

Debt

Interest coverage ration/a
CashUS$42.91m
EquityUS$31.38m
Total liabilitiesUS$16.54m
Total assetsUS$47.92m

Recent financial health updates

Recent updates

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Jul 01

Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Jan 27
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Oct 26
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Mar 26
Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation

Jun 29

Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug

Apr 04

Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Mar 22
Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

Sep 27
Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

Jun 14
We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Mar 01
We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Achieve Life Sciences prices stock offering at $7; shares down 2%

Dec 03

Achieve Life Sciences launches equity offering

Nov 30

Financial Position Analysis

Short Term Liabilities: ACHV's short term assets ($45.5M) exceed its short term liabilities ($6.7M).

Long Term Liabilities: ACHV's short term assets ($45.5M) exceed its long term liabilities ($9.8M).


Debt to Equity History and Analysis

Debt Level: ACHV has more cash than its total debt.

Reducing Debt: ACHV's debt to equity ratio has increased from 0% to 31.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ACHV has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ACHV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.7% each year


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 02:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Achieve Life Sciences, Inc. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCG Capital
Gary NachmanCGS International
Ilya ZubkovFreedom Broker